Commonwealth Consolidated Regulations

[Index] [Table] [Search] [Search this Regulation] [Notes] [Noteup] [Previous] [Download] [Help]

NATIONAL HEALTH (PHARMACEUTICALS AND VACCINES--COST RECOVERY) REGULATIONS 2022 - SCHEDULE 1

Powers of the Minister under the Act

Note:   See sections   14, 21, 23, 24, 25, 26, 27, 28, 30 and 31.

 

 

 

Powers under the Act that the Minister may be requested to exercise

Item

Powers under the Act

Part   1--Vaccines

1.1

To specify a vaccine to be a designated vaccine in a determination under subsection   9B(2) of the Act

1.2

To vary the determination of a designated vaccine under subsection   9B(2) of the Act to change the way in which a vaccine has been specified

1.3

To vary the determination of a designated vaccine under subsection   9B(2) of the Act to add a new circumstance in which the vaccine may be provided

1.4

To vary the determination of a designated vaccine under subsection   9B(2) of the Act to change a circumstance in which the vaccine may be provided but not so as to add a new circumstance

Part   2--Pharmaceuticals

2.1

To declare a drug or medicinal preparation under subsection   85(2) of the Act and, if applicable, subsection   85(2A) of the Act

2.2

To vary a declaration made under subsection   85(2) of the Act and, if applicable, subsection   85(2A) of the Act

2.3

To determine circumstances, or vary an existing determination to add a new circumstance, in which a prescription for the supply of a pharmaceutical benefit may be written under subsection   85(7) or paragraph   85(8)(b) of the Act

2.4

To vary an existing determination to change the circumstances in which a prescription for the supply of a pharmaceutical benefit may be written under subsection   85(7) or paragraph   85(8)(b) of the Act but not so as to add a new circumstance

2.5

To determine, or vary a determination about:

(a) a form of a listed drug under subsection   85(3) of the Act; or

(b) the manner of administration of a form of a listed drug under subsection   85(5) of the Act

2.6

To determine, or vary a determination, under paragraph   85(8)(a) of the Act, that a pharmaceutical benefit (other than a pharmaceutical benefit that has a drug covered by subsection   85(2A) of the Act) can only be supplied under special arrangements under section   100 of the Act

2.7

To determine matters, or vary an existing determination of matters, under subsection   85A(2) of the Act, with respect to the writing of prescriptions by a specified class of persons for the supply of a pharmaceutical benefit

2.8

To specify, or vary the specification of, a class of persons in a determination made under subsection   85A(1) or (2) of the Act

2.9

To determine for the purposes of subsection   88(1), (1A), (1C), (1D) or (1E) of the Act a pharmaceutical benefit the supply of which a PBS prescriber referred to in that subsection is authorised to write a prescription, or to vary such a determination

2.10

To vary the specification of a pharmaceutical item under subsection   84AAA(2) of the Act so that it no longer applies to a pharmaceutical benefit

2.11

To make a determination about the supply of a pharmaceutical benefit under section   93, 93AA or 93AB of the Act

2.12

To make or vary a special arrangement under section   100 of the Act to provide for the supply of pharmaceutical benefits

2.13

To specify a circumstance in which a pharmaceutical benefit may be supplied in a special arrangement made under section   100 of the Act, or to vary an existing special arrangement to specify a new circumstance

2.14

To vary the circumstances in which a pharmaceutical benefit may be supplied in an existing special arrangement made under section   100 of the Act but not so as to add a new circumstance

2.15

To agree on a new price for a single brand of a combination item under subsection   99ACC(3) of the Act

Note:   The Committee may advise the Minister about this under subsection   101(4AC) of the Act.

2.16

To determine that a pharmaceutical item is an exempt item under section   84AH of the Act

Note:   The Committee may advise the Minister about this under subsection   101(4AB) of the Act.

2.17

To revoke or vary, under subsection   101(4AAE) of the Act, a declaration under subsection   85(2A) of the Act so that a listed drug is generally available for supply under Part   VII of the Act rather than available only under special arrangements under section   100 of the Act

2.18

To enter into a deed with a person under section   85E of the Act or to vary a deed entered into with a person under section   85E of the Act

Part   3--Existing pharmaceutical items

3.1

To determine a brand under subsection   85(6) of the Act for a pharmaceutical item that has a listed brand

 



AustLII: Copyright Policy | Disclaimers | Privacy Policy | Feedback